Robin C. Kopelman, M.D., M.P.H. Clinical Assistant Professor, University of Iowa Department of Psychiatry Co-Director, Women’s Wellness and Counseling Service Iowa Depression and Clinical Research Center September 17, 2013 Mental Health and Contraception
42
Embed
Robin C. Kopelman, M.D., M.P.H. Clinical Assistant Professor, University of Iowa Department of Psychiatry Co-Director, Women’s Wellness and Counseling.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Robin C. Kopelman, M.D., M.P.H.Clinical Assistant Professor, University of Iowa
Department of PsychiatryCo-Director, Women’s Wellness and Counseling Service
Iowa Depression and Clinical Research CenterSeptember 17, 2013
Mental Health and Contraception
Overview
Epidemiology of mood disorders in womenReproductive hormones and mood in
womenMood effects of hormone-based
contraceptionMood symptoms and contraceptive useContraception and preconception
counseling
Major Depressive Episode: Diagnostic Criteria 5 of 9 symptoms, including 1 or 3
(SIGECAPS) 1 depressed mood2 thoughts of death, Suicidal ideation 3 anhedonia or diminished Interest4 worthless or Guilty 5 fatigue, loss of Energy 6 poor Concentration, indecisiveness 7 change in Appetite8 Psychomotor retardation or agitation9 change in Sleep (insomnia or hypersomnia)
Depression: A “women’s issue”
Overall rates: 12% per year, 20% lifetime
Compared to men: 2 – 3 times more common
Difference starts in adolescence
Premenstrual depression/anxiety
Depression during pregnancy
Depression during the postpartum period
Menarche MenopausePregnancy
Depression associated with infertility,
miscarriage, or perinatal loss
Depression/anxiety during the
perimenopausal period
Depression Across the Female Reproductive Cycle
CONTRACEPTION
Not just hormones…
Reproductive hormones are neuroactiveProgesterone and metabolites
GABA
Estrogen and progesteroneMAOOpioid, serotonergic, cholinergic NTs
Not simple relationship to moodU shaped dose-responseFluctuations, not absolute levels
What do we see clinically?Premenstrual Dysphoric Disorder
Depressive symptoms confined to luteal phase
3 – 8 % of women of reproductive age
EtiologyDecreased luteal phase serotonin activity related to hormone shifts (progesterone)
PMS ≠ PMDD
O'Hara, 1986; O'Hara & Swain, 1986; Hobfoll et al., 1995; Seguin et al., 1999
Antenatal Depression
10 – 20% of women during pregnancy Select group - role
for hormones
Bonari et al 2004;Kelly et al., 1999; Kelly et al., 2002;Deave et al., 2008